[1] GIUDICE L C,KAO L C.Endometriosis[Z].Lancet.2004:364(9447),1789-1799. [2] HÄRKKI P,TIITINEN A,YLIKORKALA O.Endometriosis and assisted reproduction techniques[J].Ann N Y Acad Sci,2010(1205):207-213. [3] 中华医学会妇产科学分会子宫内膜异位症协作组.子宫内膜异位症的诊治指南[J].中华妇产科杂志,2015(3):161-169. [4] Revised American Society for Reproductive Medicine classification ofendometriosis:1996[J].Fertil Steril,1997,67(5):817-821. [5] 中国医师协会妇产科医师分会,中华医学会妇产科学分会子宫内膜异位症协作组.子宫内膜异位症诊治指南(第三版)[J].中华妇产科杂志,2021,56(12):812-824. [6] EISENBERG V H,DECTER D H,CHODICK G,et al.Burden of endometriosis:Infertility,comorbidities,and healthcare resource utilization[J].J Clin Med,2022,11(4):1133. [7] BESTE M T,PFAFFLE-DOYLE N,PRENTICE E A,et al.Molecular network analysis of endometriosis reveals a role for c-Jun-regulated macrophage activation[J].Sci Transl Med,2014,6(222):222ra-16. [8] WU J,XIE H,YAO S,et al.Macrophage and nerve interaction in endometriosis[J].J Neuroinflam,2017,14(1):53. [9] MACER M L,TAYLOR H S.Endometriosis and infertility:a review of the pathogenesis and treatment of endometriosis-associated infertility[J].Obstet Gynecol Clin North Am,2012,39(4):535-549. [10] 焦艳,夏红慧.卵丘颗粒细胞质量及IL-6、CRP变化对IVF-ET治疗子宫内膜异位症不孕临床结局的影响[J].中国计划生育学杂志,2021,29(4):759-762,855. [11] 朱靓雯,薛晴.子宫内膜容受性与子宫内膜异位症相关性不孕[J].中华生殖与避孕杂志,2020,40(3):246-249. [12] COCCIA M E,RIZZELLO F,MARIANI G,et al.Impact of endometriosis on in vitro fertilization and embryo transfer cycles in young women:a stage-dependent interference.[J].Acta Obstet Gyn Scan,2011,90(11):1232-1238. [13] 王俊霞,侯晓妮,朱静静,等.卵巢储备功能正常的中重度子宫内膜异位症患者超长方案行IVF 促排卵及妊娠结局[J].中国生育健康杂志,2015(5):408-411. [14] KUIVASAARI P,HIPPELÄINEN M,ANTTILA M,et al.Effect of endometriosis on IVF/ICSI outcome:stage /Ⅳ endometriosis worsens cumulative pregnancy and live-born rates[J].Hum Reprod,2005,20(11),3130-3135. [15] POP-TRAJKOVIC S,POPOVIĆ J,ANTIĆ V,et al.Stages of endometriosis:does it affect in vitro fertilization outcome[J].Taiwan J Obstet Gyne,2014,53(2):224-226. [16] TAMURA H,TAKASAKI A,NAKAMURA Y,et al.A pilot study to search possible mechanisms of ultralong gonadotropin-releasing hormone agonist therapy in IVF-ET patients with endometriosis[J].J Ovarian Res,2014(7):100. [17] MIJATOVIC V,FLORIJN E,HALIM N,et al.Adenomyosis has no adverse effects on IVF/ICSI outcomes in women with endometriosis treated with long-term pituitary down-regulation before IVF/ICSI[J].Eur J Obstet Gyn Reprod Biol,2010,151(1):62-65. [18] 韩笑,陈圆辉,徐晓航,等.卵泡期长效长方案在卵巢储备良好但前次黄体期短效长方案助孕失败患者中的应用:一项自身对照研究[J].生殖与避孕,2016,36(10):792-796,806. [19] 徐嘉宁,李妍,于文竹,等.三种降调节促排方案对子宫内膜异位症患者IVF-ET结局的影响[J].生殖医学杂志,2019(2):123-128. [20] 张群芳,陈国勇,刘芸,等.促性腺激素释放激素激动剂不同降调节方案对子宫内膜异位症患者IVF结局的研究[J].生殖医学杂志,2015,24(9):732-736. [21] 鲍玉敏,曾湘晖,王莉云.子宫内膜异位症不同分期妇女行辅助生殖助孕的结局分析[J].贵州医药,2019,43(8):1271-1273. [22] SOLIMAN A M,SURREY E,BONAFEDE M,et al.Real-world evaluation of direct and indirect economic burden among endometriosis patients in the United States[J].Adv Ther,2018,35(3):408-423. |